Literature DB >> 2872880

Dual regulation of adenylate cyclase. A signal transduction mechanism of membrane receptors.

K H Jakobs, M Minuth, S Bauer, R Grandt, C Greiner, P Zubin.   

Abstract

The hormone-sensitive adenylate cyclase is a multi-component system embedded in the lipid bilayer of the plasma membrane and serves as a signal transduction system for various membrane receptors. The complete system consists of various receptor molecules, which sensitize the external ligands, the effector enzyme adenylate cyclase, which catalyzes the formation of cyclic AMP from ATP, and two guanine nucleotide-binding regulatory proteins (N or G proteins), which transduce the signals from the receptors to the adenylate cyclase. Depending on the receptor type activated by a ligand, stimulatory or inhibitory, either the stimulatory or the inhibitory N protein is activated and induces stimulation or inhibition of adenylate cyclase with subsequent increase or decrease in cellular cyclic AMP levels. In this paper, the mechanisms of this hormonal signal transduction system and its regulation will briefly reviewed, with some emphasis on the cardiac system.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2872880     DOI: 10.1007/bf01907422

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  35 in total

1.  The role of hormone receptors and GTP-regulatory proteins in membrane transduction.

Authors:  M Rodbell
Journal:  Nature       Date:  1980-03-06       Impact factor: 49.962

2.  GTP-dependent inhibition of cardiac adenylate cyclase by muscarinic cholinergic agonists.

Authors:  K H Jakobs; K Aktories; G Schultz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-12       Impact factor: 3.000

Review 3.  Inhibition of adenylate cyclase.

Authors:  K H Jakobs; K Aktories; M Minuth; G Schultz
Journal:  Adv Cyclic Nucleotide Protein Phosphorylation Res       Date:  1985

4.  Regulation of adenylate cyclase in cultured cardiocytes from neonatal rats by adenosine and other agonists.

Authors:  M B Anand-Srivastava; M Cantin
Journal:  Arch Biochem Biophys       Date:  1983-06       Impact factor: 4.013

Review 5.  Mechanisms of guanine nucleotide-mediated regulation of adenylate cyclase activity.

Authors:  M Smigel; T Katada; J K Northup; G M Bokoch; M Ui; A G Gilman
Journal:  Adv Cyclic Nucleotide Protein Phosphorylation Res       Date:  1984

6.  Modulation of adenylate cyclase of human platelets by phorbol ester. Impairment of the hormone-sensitive inhibitory pathway.

Authors:  K H Jakobs; S Bauer; Y Watanabe
Journal:  Eur J Biochem       Date:  1985-09-02

7.  Agonists differentiate muscarinic receptors that inhibit cyclic AMP formation from those that stimulate phosphoinositide metabolism.

Authors:  J H Brown; S L Brown
Journal:  J Biol Chem       Date:  1984-03-25       Impact factor: 5.157

8.  Isolation of two proteins with high affinity for guanine nucleotides from membranes of bovine brain.

Authors:  P C Sternweis; J D Robishaw
Journal:  J Biol Chem       Date:  1984-11-25       Impact factor: 5.157

Review 9.  Forskolin: a unique diterpene activator of cyclic AMP-generating systems.

Authors:  K B Seamon; J W Daly
Journal:  J Cyclic Nucleotide Res       Date:  1981

10.  Flow of information in the light-triggered cyclic nucleotide cascade of vision.

Authors:  B K Fung; J B Hurley; L Stryer
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

View more
  3 in total

Review 1.  Phosphodiesterase inhibition by new cardiotonic agents: mechanism of action and possible clinical relevance in the therapy of congestive heart failure.

Authors:  H von der Leyen
Journal:  Klin Wochenschr       Date:  1989-06-15

2.  Guanine nucleotide-independent inhibition of adenylate cyclase by a stimulatory hormone.

Authors:  C Greiner; K H Jakobs
Journal:  Biochem J       Date:  1988-08-15       Impact factor: 3.857

3.  Pertussis toxin and N-ethylmaleimide inhibit histamine- but not calcium ionophore-induced endothelium-dependent relaxation.

Authors:  G Weinheimer; H Osswald
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989 Jan-Feb       Impact factor: 3.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.